We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Industry

Illustration

Global Clinical Immunoanalyzers Market to Be Driven by High Incidence of Chronic and Infectious Diseases

The global clinical immunoanalyzers market has been witnessing high demand due to the high prevalence and incidence rates of chronic and infectious diseases, rapid growth in the elderly population, strong economic growth in the emerging markets, decline in oil prices, and health insurance reforms globally. However, low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes have been hampering market growth. More...
28 Dec 2021
Illustration

Global Point-of-Care Molecular Diagnostics Market to Be Driven by Rising Instances of Infectious Diseases

The global market for point-of-care (PoC) molecular diagnostics is predicted to record a solid growth over the next couple of years due to a rise in instances of infectious diseases and increasing public awareness about pre-disease detection. Additionally, growing research and development due to increased funding by both government and private entities, leading to new and better products being rolled out, will also have a positive impact on the market. More...
27 Dec 2021
Illustration

Quidel Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

Quidel Corporation (San Diego, CA, USA) and Ortho Clinical Diagnostics (Raritan, NJ, USA) have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies. More...
24 Dec 2021
Illustration

Clinical Laboratory Tests Market Driven by Demand for Molecular, Pathological and Immunological Testing

The global clinical laboratory tests market is expected to surpass USD 327 billion by 2028, driven by a growing geriatric population and increasing molecular, pathological, and immunological tests. More...
17 Dec 2021
Illustration

Global In-Vitro Diagnostics (IVD) Market to Surpass USD 115 Billion in 2028 Due to Increasing COVID-19 Test Volumes

The global in-vitro diagnostics (IVD) market is expected to reach USD 117.54 billion in 2028, driven by a rise in geriatric population worldwide, growing awareness of regular body profiling, surging prevalence of chronic diseases such as cancer and diabetes, and increasing sales of over-the-counter diagnostic devices such as glucose monitoring kits. More...
14 Dec 2021
Illustration

Global POC Diagnostics Market to Reach Nearly USD 90 Billion Due to Growing Demand for Rapid COVID-19 Test Kits

The global point of care (POC) diagnostics market is estimated to grow at a CAGR of 12.7% from approximately USD 36 billion in 2021 to nearly USD 90 billion in 2028, driven by the increasing prevalence of infectious diseases, product developments and launches, and rise in the number of CLIA-waived POC tests. However, product recalls are expected to hamper market growth. More...
13 Dec 2021
Illustration

Eurofins Acquires Genetic Lab Co. to Enhance Clinical and COVID-19 Testing Offering in Japan

Eurofins Scientific (Ebersberg, Germany) has entered into an agreement to acquire Genetic Lab Co., Ltd. (Japan), a molecular biology based testing provider for diagnostics, biomarker development and drug discovery. More...
13 Dec 2021
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Entamoeba One Step Card Test
CerTest Entamoeba
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2024 Globetech Media. All rights reserved.